检索结果 - Favre‐Guilmard, Christine
- Showing 1 - 4 results of 4
-
1
Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems 由 Elliott, Mark, Maignel, Jacquie, Liu, Sai Man, Favre-Guilmard, Christine, Mir, Imran, Farrow, Paul, Hornby, Fraser, Marlin, Sandra, Palan, Shilpa, Beard, Matthew, Krupp, Johannes
出版 2017Text -
2
A comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivo 由 Donald, Sarah, Elliott, Mark, Gray, Bryony, Hornby, Fraser, Lewandowska, Agnieszka, Marlin, Sandra, Favre‐Guilmard, Christine, Périer, Cindy, Cornet, Sylvie, Kalinichev, Mikhail, Krupp, Johannes, Fonfria, Elena
出版 2018Text -
3
Recombinant botulinum neurotoxin serotype A1 in vivo characterization 由 Périer, Cindy, Martin, Vincent, Cornet, Sylvie, Favre‐Guilmard, Christine, Rocher, Marie‐Noelle, Bindler, Julien, Wagner, Stéphanie, Andriambeloson, Emile, Rudkin, Brian, Marty, Rudy, Vignaud, Alban, Beard, Matthew, Lezmi, Stephane, Kalinichev, Mikhail
出版 2021Text -
4
Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models 由 Elliott, Mark, Favre-Guilmard, Christine, Liu, Sai Man, Maignel, Jacquie, Masuyer, Geoffrey, Beard, Matthew, Boone, Christopher, Carré, Denis, Kalinichev, Mikhail, Lezmi, Stephane, Mir, Imran, Nicoleau, Camille, Palan, Shilpa, Perier, Cindy, Raban, Elsa, Zhang, Sicai, Dong, Min, Stenmark, Pål, Krupp, Johannes
出版 2019Text